Danaher stock trades at EUR 195.85 before third-quarter results

Published on 10/21/2026 at 11:34 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Results are due October 21, 2026, with consensus revenue of USD 6.56 billion. Danaher stock costs EUR 195.85 on October 21, 2026, 2.37 percent below the Xetra close.

Earnings expectations and targets

TD Cowen lifted its Danaher target from USD 236.00 to USD 255.00 on October 13, 2026.
Consensus revenue of USD 6.56 billion compares with USD 6.05 billion in the year-ago quarter.
Danaher stock trades at EUR 195.85 at 11:31 a.m. CEST at Lang & Schwarz on October 21, 2026, 2.37 percent below the Xetra close of October 20, 2026.

Flatlay mit Aktienzertifikat, ISIN-Karte US2358511028, Pipetten und Laborutensilien auf weißem Marmor — Danaher Corp. Aktien-Zertifikat und ISIN-Karte US2358511028 im Flatlay mit Laborutensilien auf weißem Marmor, Illustration mit AI erstellt.

Danaher Corp. (ISIN US2358511028) was trading at EUR 195.85 at Lang & Schwarz on October 21, 2026, at 11:31 a.m. CEST, 2.37 percent below the Xetra close of October 20, 2026 at EUR 200.60. Investing.com reported on October 20, 2026 that Danaher was scheduled to release third-quarter results before the US market opened on October 21, 2026. The figures will test whether bioprocessing demand is stabilizing under CEO Julie Sawyer Montgomery.

Analysts reset targets higher

Benzinga reported that RBC Capital raised its target from USD 215.00 to USD 250.00 on October 5, 2026, Barclays lifted its target from USD 230.00 to USD 255.00 on October 7, 2026, and TD Cowen raised its target from USD 236.00 to USD 255.00 on October 13, 2026. Each call kept a positive rating on the stock.

The analyst reset sits beside Danaher's second-quarter revenue of USD 6.27 billion, up 5.50 percent from the year-ago quarter, according to Simply Wall St on October 21, 2026. That operating comparison gives the coming report a concrete baseline rather than leaving the recovery thesis to analyst targets alone.

What does the earnings setup require?

Benzinga cited consensus of USD 6.56 billion in third-quarter revenue and USD 1.92 in earnings per share, against USD 6.05 billion and USD 1.89 in the year-ago quarter. Those inputs imply revenue growth of 8.43 percent and earnings-per-share growth of 1.59 percent, putting more weight on the quality of bioprocessing demand than on headline sales alone.

Three dates frame the setup

The next substantiated event is Danaher's third-quarter results release on October 21, 2026, before the US market opens, as reported by Investing.com.

Stock price and investor view

Danaher's EUR 195.85 quote sits below the EUR 200.60 Xetra close used as the dated reference base. The market is therefore entering the report with a weaker German trading indication even as analysts have raised targets and consensus anticipates higher revenue than a year earlier. The further course of trading is shown by the continuously updated real-time quote of Danaher stock.